The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anti-tumor activity of FF-10850 (liposomal topotecan) in patients with advanced Merkel cell carcinoma.
 
Vincent Ma
Honoraria - CAHON; Conquer Cancer, the ASCO Foundation; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Bristol Myers Squibb; Delcath Systems; General Dynamics Information Technology; IDEAYA Biosciences; Immunocore; Incyte; MDoutlook; Partner Therapeutics; Regeneron; Replimune; Targeted Oncology; Teiko.bio; Y-mAbs Therapeutics
Research Funding - AIQ Solutions (Inst); Aminex (Inst); Astellas Pharma (Inst); C4 Therapeutics (Inst); Delcath Systems; Fujifilm (Inst); immatics (Inst); Immuneering (Inst); Immunocore (Inst); Innate Pharma (Inst); Jounce Therapeutics (Inst); Krystal Biotech (Inst); Marengo Therapeutics (Inst); Merck (Inst); Natera (Inst); Pfizer (Inst); Regeneron (Inst); Replimune (Inst); Seagen (Inst); Top Alliance BioScience (Inst); TuHura Biosciences (Inst); Y-mAbs Therapeutics (Inst)
Travel, Accommodations, Expenses - CAHON; Delcath Systems; Erasca, Inc; Immunocore; Incyte; Regeneron
 
Claire Verschraegen
Consulting or Advisory Role - CTI; Sun Pharma
 
Justin Moser
Honoraria - Caris Life Sciences; Curio Science (2024); Daiichi Sankyo/Lilly; Horizon CME; IDEOlogy Health; TGen
Consulting or Advisory Role - Adagene; Amunix; Boxer Capitol; Bristol Myers Squibb Foundation; Genome Insight; Imaging Endpoints; Immunocore; Incyte; Iovance Biotherapeutics (2025); IQvia; Novotech; Oberland Capital; Pfizer (2023); Red Arrow Therapeutics; Replimune (2024); Sun Pharma; Thirona Biosciences; Vilya (2024); Werewolf Therapeutics (Inst)
Speakers' Bureau - Caris Life Sciences; Castle Biosciences; Immunocore
Research Funding - Adaptimmune (Inst); Agenus (Inst); Alpine Immune Sciences (Inst); Amgen (Inst); BioEclipse Therapeutics (Inst); Brightpeak Therapeutics (Inst); Fate Therapeutics (Inst); Fujifilm (Inst); Genentech (Inst); IDEAYA Biosciences (Inst); immatics (Inst); ImmuneSensor Therapeutics (Inst); iOnctura; Iovance Biotherapeutics (Inst); Istari Oncology (Inst); Nektar (Inst); NovelWise Pharma; Novocure (Inst); Orionis (Inst); Repertoire Immune Medicines (Inst); Replimune (Inst); Rubius Therapeutics (Inst); Senhwa Biosciences (Inst); Simcha Therapeutics (Inst); Sparx Therapeutics (Inst); Storm Therapeutics (Inst); Synthorx (Inst); T-Scan Therapeutics (Inst); Trishula Therapeutics (Inst); Trutino Biosciences; University of Arizona (Inst); Werewolf Therapeutics (Inst); Y-mAbs Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - PATENT: US PCT/US24/27766 (PENDING)
Other Relationship - Caris Consultant (12/2021); Caris Life Sciences
 
Jasgit Sachdev
Employment - Biosplice; IDEAYA Biosciences
Stock and Other Ownership Interests - Biosplice; IDEAYA Biosciences
Travel, Accommodations, Expenses - IDEAYA Biosciences
Other Relationship - IDEAYA Biosciences; IDEAYA Biosciences
 
David Wages
Stock and Other Ownership Interests - iSpecimen
Consulting or Advisory Role - Fujifilm; KM Pharmaceutical Consulting; Nested; TD2
 
Mikinaga Mori
Employment - Fujifilm
 
Susumu Shimoyama
Employment - Fujifilm
Leadership - Fujifilm
Patents, Royalties, Other Intellectual Property - I report patents, WO/2008/026584, WO/2019/244979, WO/2020/071349, WO/2021/060307, WO/2021/125229, WO/2022/250013, WO/2022/250015, WO/2024/111564
 
Naoki Yamada
Employment - Fujifilm
Stock and Other Ownership Interests - Fujifilm
Patents, Royalties, Other Intellectual Property - I am listed as the inventor of FF-10850 on the patent.
 
Ruth Subach
Employment - Fujifilm
Stock and Other Ownership Interests - Pfizer; Trevena
Travel, Accommodations, Expenses - Fujifilm
 
Kin Cheung
Stock and Other Ownership Interests - Moderna Therapeutics (I)
Consulting or Advisory Role - Fujifilm Pharmaceutical, USA; Protego Biopharma; PureTech; Seaport Therapeutic
Travel, Accommodations, Expenses - Fujifilm Pharmaceutical, USA
 
Timothy Madden
Employment - Fujifilm; Fujifilm (I)
Patents, Royalties, Other Intellectual Property - 60 patents held from my previous work as a faculty member at the University of Texas MD Anderson Cancer Center
Travel, Accommodations, Expenses - Fuji Pharma (I); Fujifilm
 
Gary Maier
Employment - Fuji Pharma
Stock and Other Ownership Interests - SPDR S and P Biotech ETF
Consulting or Advisory Role - Fuji Pharma
 
Mary Johansen
Employment - Fujifilm
Patents, Royalties, Other Intellectual Property - Spouse receives patent royalties from Pharma (I)
Travel, Accommodations, Expenses - Fujifilm
 
Gerald Falchook
Employment - HealthONE; Sarah Cannon Research Institute
Honoraria - Clinical Care Options
Consulting or Advisory Role - Abbvie (Inst); BostonGene (Inst); BostonGene (Inst); BridgeBio Pharma (Inst); EMD Serono; Fujifilm (Inst); Inspirna (Inst); Jubilant Pharmaceuticals (Inst); Merck (Inst); Navire (Inst); Predicine (Inst); Regeneron (Inst); Sanofi (Inst); Silicon Therapeutics (Inst); Silicon Therapeutics (Inst); Teon Therapeutics (Inst); Turning Point Therapeutics (Inst)
Speakers' Bureau - Total Health Conferencing
Research Funding - 3-V Biosciences (Inst); Abbisko (Inst); Abbvie (Inst); ABL Bio (Inst); Accutar Biotech (Inst); ADC Therapeutics (Inst); Agenus (Inst); Aileron Therapeutics (Inst); American Society of Clinical Oncology (Inst); Amgen (Inst); ARMO BioSciences (Inst); Artios (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bicycle Therapeutics (Inst); Bioatla (Inst); BioInvent (Inst); Biomea Fusion (Inst); Biothera (Inst); Black Diamond Therapeutics (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Celldex (Inst); Centessa Pharmaceuticals (Inst); Ciclomed (Inst); Conjupro Biotherapeutics (Inst); Curegenix (Inst); Curis (Inst); Cyteir (Inst); Daiichi (Inst); DelMar Pharmaceuticals (Inst); eFFECTOR Therapeutics (Inst); Eikon Therapeutics (Inst); EMD Serono (Inst); Epizyme (Inst); Erasca, Inc (Inst); Exelixis (Inst); Freenome (Inst); Fujifilm (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Harbour BioMed (Inst); Hutchison MediPharma (Inst); IDEAYA Biosciences (Inst); IgM Biosciences (Inst); Ignyta (Inst); Immunitas (Inst); Immunogen/MacroGenics (Inst); Incyte (Inst); Jacobio (Inst); Jazz Pharmaceuticals (Inst); Jounce Therapeutics (Inst); Jubilant Pharmaceuticals (Inst); Kineta (Inst); Kolltan Pharmaceuticals (Inst); Kura Oncology (Inst); Lilly (Inst); Loxo (Inst); MD Anderson Cancer Center (Inst); MedImmune (Inst); Merck (Inst); Metabomed (Inst); Millennium (Inst); Mirati Therapeutics (Inst); miRNA Therapeutics (Inst); Molecular Templates (Inst); National Institute of Health (NIH) (Inst); Navire (Inst); NGM Biopharmaceuticals (Inst); NiKang Therapeutics (Inst); Novartis (Inst); Nuvectis Pharma (Inst); OncoMed (Inst); Oncorus (Inst); Oncothyreon (Inst); Phanes Therapeutics (Inst); Poseida (Inst); Precision Oncology (Inst); Prelude Therapeutics (Inst); PureTech (Inst); Pyramid Biosciences (Inst); Pyxis (Inst); RasCal (Inst); Regeneron (Inst); Relay Therapeutics (Inst); Rgenix (Inst); Ribon Therapeutics (Inst); Roche (Inst); Samumed (Inst); Sapience Therapeutics (Inst); Sarah Cannon Research Institute (Inst); Seagen (Inst); Silicon Therapeutics (Inst); Simcha Therapeutics (Inst); Sirnaomics (Inst); Strategia Therapeutics (Inst); Syndax (Inst); Synthorx (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tallac Therapeutics (Inst); Tango Therapeutics (Inst); Tarus Therapeutics (Inst); Tarveda Therapeutics (Inst); TeneoBio (Inst); Tesaro (Inst); Tocagen (Inst); Turning Point Therapeutics (Inst); Vegenics (Inst); Xencor (Inst); Zhuhai Yufan Biotechnologies (Inst)
Patents, Royalties, Other Intellectual Property - Handbook of Targeted Cancer Therapy
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; EMD Serono; Fujifilm; Millennium; Sarah Cannon Research Institute; Synthorx/Sanofi